McKesson Corp. (MCK) News
Filter MCK News Items
MCK News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
MCK News Highlights
- For MCK, its 30 day story count is now at 10.
- Over the past 17 days, the trend for MCK's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- TOP and DRUG are the most mentioned tickers in articles about MCK.
Latest MCK News From Around the Web
Below are the latest news stories about MCKESSON CORP that investors may wish to consider to help them evaluate MCK as an investment opportunity.
Silver Economy Successes: 3 Stocks Benefitting From an Aging PopulationExplore our in-depth analysis of aging population stocks, uncovering the opportunities and challenges in this sector. |
McKesson Corporation Announces Third Quarter Fiscal 2024 Earnings Release Date and Participation in January ConferenceIRVING, Texas, December 27, 2023--McKesson Corporation (NYSE: MCK) will release its third quarter fiscal 2024 financial results after market close on Wednesday, February 7, 2024. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results. |
McKesson (MCK) Announces Availability of PNH's FDA-Approved DrugThe availability of the FDA-approved drug via McKesson's (MCK) independent specialty pharmacy is expected to give patients more treatment options for PNH. |
McKesson's (NYSE:MCK) five-year earnings growth trails the 34% YoY shareholder returnsFor many, the main point of investing in the stock market is to achieve spectacular returns. And we've seen some truly... |
Why McKesson (MCK) is a Top Value Stock for the Long-TermThe Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage. |
Institutional investors in McKesson Corporation (NYSE:MCK) lost 3.1% last week but have reaped the benefits of longer-term growthKey Insights Institutions' substantial holdings in McKesson implies that they have significant influence over the... |
13 Most Profitable Pharmaceutical Stocks NowIn this article, we discuss the 13 most profitable pharmaceutical stocks to buy. You can skip our detailed analysis of the pharmaceutical sector and its outlook this year, and go directly to read the 5 Most Profitable Pharmaceutical Stocks Now. The healthcare sector encompasses a diverse range of companies, spanning pharmaceuticals, medical equipment and device […] |
Top 30 Largest US Companies by 2023 RevenueIn this article, we will be covering the top 30 largest US companies by 2023 revenue. If you want to skip our detailed analysis, you can go directly to the Top 5 Largest US Companies by 2023 Revenue. The United States is home to some of the most valuable companies in the world. The US […] |
Here's Why You Should Retain McKesson (MCK) Stock for NowMcKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment. |
McKesson (MCK) Announces Availability of FDA-Approved DrugThe availability of the FDA-approved drug via McKesson's (MCK) independent specialty pharmacy is expected to give patients more treatment options for desmoid tumors. |